These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. THE USE OF HALLUCINOGENIC, PSYCHOTOMIMETIC, PSYCHEDELIC DRUGS IN NORTH CAROLINA. KEELER MH N C Med J; 1963 Dec; 24():555-7. PubMed ID: 14089896 [No Abstract] [Full Text] [Related]
7. Lysergic acid diethylamide (LSD-25). XXXI. Comparison by questionnaire of psychotomimetic activity of congeners on normal subjects and drug addicts. ABRAMSON HA J Ment Sci; 1960 Jul; 106():1120-3. PubMed ID: 13681136 [No Abstract] [Full Text] [Related]
8. Studies on lysergic acid diethylamide and related compounds. Part 8. Structural identification of new metabolites of lysergic acid diethylamide obtained by microbial transformation using Streptomyces roseochromogenes. Ishii H; Niwaguchi T; Nakahara Y; Hayashi M J Chem Soc Perkin 1; 1980; 4():902-5. PubMed ID: 7190156 [No Abstract] [Full Text] [Related]
10. [Studies on lysergic acid diethylamide and related compounds. IV. Syntheses of various amide derivatives of norlysergic acid and related compounds]. Niwaguchi T; Nakahara Y; Ishii H Yakugaku Zasshi; 1976 May; 96(5):673-8. PubMed ID: 987200 [No Abstract] [Full Text] [Related]
11. THE PSYCHOTOMIMETIC DRUGS. AN OVERVIEW. COLE JO; KATZ MM JAMA; 1964 Mar; 187():758-61. PubMed ID: 14094299 [No Abstract] [Full Text] [Related]
12. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide). ABRAMSON HA; SKLAROFSKY B; BARON MO; FREMONT-SMITH N AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):201-7. PubMed ID: 13497364 [No Abstract] [Full Text] [Related]
13. The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: an open, non-randomized case series. Karst M; Halpern JH; Bernateck M; Passie T Cephalalgia; 2010 Sep; 30(9):1140-4. PubMed ID: 20713566 [No Abstract] [Full Text] [Related]
14. [Molecular modeling of N-isopropyl lisergamides analogous to LSD using molecular mechanics and quantum mechanical calculations]. Cordero de Troconis MI; Pfaff R; Nichols D Acta Cient Venez; 1997; 48(2):85-90. PubMed ID: 9567327 [TBL] [Abstract][Full Text] [Related]
15. [Interaction between monoamine oxidase inhibitors and psychotomimetic drugs]. CAZZULLO CL; GOLDWURM GF Rass Studi Psichiatr; 1962; 51():979-93. PubMed ID: 14019547 [No Abstract] [Full Text] [Related]
16. A Receptor on Acid. Chen Q; Tesmer JJG Cell; 2017 Jan; 168(3):339-341. PubMed ID: 28129534 [TBL] [Abstract][Full Text] [Related]
17. Studies on lysergic acid diethylamide and related compounds. VII. Microbial transformation of lysergic acid diethylamide and related compounds. Ishii H; Hayashi M; Niwaguchi T; Nakahara Y Chem Pharm Bull (Tokyo); 1979 Jul; 27(7):1570-5. PubMed ID: 540347 [No Abstract] [Full Text] [Related]